Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced that CEO Dr. Kevin Rodan Levy plans to attend HLTH Europe 2026, an international healthcare conference focused on digital health and innovation. The event will take place in Amsterdam from June 15-18.
Dr. Levy's attendance is intended to support the Company's broader strategic initiatives, including engagement with healthcare industry participants, evaluation of emerging technologies and market developments, and exploration of strategic relationships that may support the continued development and expansion of the Company's evolving digital health ecosystem. The Company believes that attendance at major international healthcare conferences may provide valuable opportunities to observe industry developments, strengthen professional networks, and support its broader efforts to advance its telehealth and artificial intelligence healthcare platform strategy.
HLTH Europe is expected to convene healthcare executives, innovators, investors, and technology leaders from across global markets to discuss healthcare transformation, digital infrastructure, and advancements in healthcare delivery. This provides the Company with valuable opportunities to observe industry developments and engage with broader healthcare innovation trends.
Dr. Levy stated: "As we continue advancing our digital health and artificial intelligence initiatives, attending major international healthcare events provides valuable opportunities to observe emerging industry trends, engage with healthcare innovators, and further strengthen our long-term strategic positioning."
The Company continues to advance the development of its telehealth platform infrastructure, artificial intelligence healthcare modules, and broader digital health strategy across Latin America and emerging markets. For more information, visit https://catalystcrewai.com or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
